Reference only — not a dosing recommendation.
Product-, indication-, and jurisdiction-specific — see the monograph
- Acute heart failure (Japan label): 0.0125–0.05 mcg/kg/min IV continuous infusion. No bolus dose. Higher rates may increase hypotension risk.
Studied in trials — not a recommended dose
- COMPASS: 0.0125–0.05 mcg/kg/min IV.
- Other studies: 0.1 mcg/kg/min (associated with more hypotension).
- Mortality benefit not demonstrated.
- Use outside Japan in controlled settings.
- No established or recommended human dose for unapproved indications.
Carperitide — section dose et administration de la monographie